- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03985111
Does a Central Venous Line Reduce Perioperative Fluid Administration?
In High Risk Patients Undergoing Elective Colorectal Resection, Does Routine Placement of a Central Venous Catheter Reduce Peri-operative Fluid Administration in Theatre and the Critical Care Unit?
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
There are several indications for elective central venous cannulation in major colorectal surgery, particularly in those at a higher risk of morbidity and mortality. These include: the ability to infuse certain vasoactive medications, monitor central venous pressure, allow for frequent blood sampling, and provide a route of access for total parenteral nutrition(1). Furthermore, there has been a great deal of recent interest in whether there are improved outcomes with restrictive as opposed to liberal fluid therapy in major abdominal surgery(2), and, similarly, with individualised, rather than generic, blood pressure management in major surgery(3). However, there have been no major studies to date examining whether the simple act of electively inserting a central venous catheter prior to the start of surgery influences the volume of fluid infused and the use of vasopressors perioperatively.
The RELIEF trial reported that modestly liberal perioperative fluid regimens conferred no greater disability-free survival benefit over restrictive regimens, but are likely to reduce rates of acute kidney injury(2). This contrasts with the restrictive protocols championed by various Enhanced Recovery After Surgery (ERAS) programs(4). Previous works have suggested that not only does adherence to ERAS principles lead to superior patient outcomes, but some have gone further in identifying restriction of intravenous fluids perioperatively to be one of the few interventions that independently predicts a better outcome(5). One of the advantages of central venous catheterisation is the ability to administer drugs in smaller volumes of fluid. Therefore, given the intensity of the debate surrounding restrictive and liberal regimens, it should be investigated whether the availability of central venous access impacts upon the volumes of fluid infused.
Furthermore, central venous catheterisation is unlikely just to have an impact via the avoidance of inadvertent larger volume infusion, which is sometimes seen with drug administration through a peripheral line. The RELIEF trial reported that the patient cohort managed with a restrictive fluid regimen were more likely to receive vasopressor support, compared with those receiving a liberal regimen(2). The presence of a central venous catheter enables the use of potent vasopressor agents, such as noradrenaline, which will further influence fluid administration, by introducing a second therapeutic option for correcting perioperative hypotension. The importance of 'tight' blood pressure control has been demonstrated by the INPRESS trial, which showed a reduction in post-operative organ dysfunction with individualised blood pressure management, over standard management strategies(3). This is of particular importance, as evidence has shown that cardiac output-directed fluid therapy should not lead to 'excessive fluid administration, but may lead to a more individualised approach to achieving the correct dose of fluid'(6), and may require concomitant use of vasoactive agents.
Thus, the investigators have set out to investigate whether the elective insertion of a central venous catheter prior to the start of major colorectal surgery, influences the volumes, and types, of fluid infused, as well as the use and mean dose of vasopressor agents, intra-operatively and for the first 12 hours post-operatively.
- Smith, RN, et al., 'Central venous catheters', BMJ 2013; 347:f6570
- Myles, PS, et al., 'Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery', N Engl J Med 2018; 378:24
- Futier, E, et al., 'Effect of Individualised vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery', JAMA 2017; 318(14):1346
- Feldheiser, A, et al., 'Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice', Acta Anaesthesiologica Scandinavia 2016, 60:289
- Gustafsson, UO, et al., 'Adherence to the Enhanced Recovery After Surgery Protocol and Outcomes After Colorectal Cancer Surgery', Arch Surg 2011; 146(5):571
- Pearse, RM, et al., 'Effect of a Perioperative Cardiac Output- Guided Haemodynamic Therapy Algorithm on Outcomes Following Major Gastrointestinal Surgery', JAMA 2014; 311(21):2181
Typ studie
Zápis (Aktuální)
Kontakty a umístění
Studijní místa
-
-
-
London, Spojené království, E11 1NR
- Whipps Cross Hospital, Barts Health NHS Trust
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
The inclusion criteria will be all adult patients presenting for elective major colorectal surgery (resection), whom are to be electively admitted to critical care directly from theatre.
Exclusion Criteria:
- Patients under 18 years of age
- Patients undergoing emergency surgery
- Those not admitted electively to critical care directly from theatre
- Those patients that do not undergo any bowel resection
- Patients in whom central venous catheter insertion is as an emergency peri- operatively
- Patients refusing/unable to give valid informed consent
Studijní plán
Jak je studie koncipována?
Detaily designu
Kohorty a intervence
Skupina / kohorta |
Intervence / Léčba |
|---|---|
|
No CVC inserted
Patients undergoing major elective colorectal resection without central venous catheter inserted pre-operatively
|
|
|
CVC inserted
Patients undergoing major elective colorectal resection with a central venous catheter inserted pre-operatively
|
Insertion of a central venous catheter insertion pre-operatively (electively)
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Volume of intravenous fluid infused intra-operatively
Časové okno: Intra-operatively (from induction to leaving theatre)
|
To assess whether the presence of a central venous catheter influences the volume of intravenous fluid infused intra-operatively
|
Intra-operatively (from induction to leaving theatre)
|
|
Volume of intravenous fluid infused post-operatively
Časové okno: The first 12 hours post-operatively (commencing from the arrival on the critical care unit, until the end of the 12th post-operative hour)
|
To assess whether the presence of a central venous catheter influences the volume of intravenous fluid infused post-operatively
|
The first 12 hours post-operatively (commencing from the arrival on the critical care unit, until the end of the 12th post-operative hour)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Length of Intensive Care Unit Stay
Časové okno: From admission to intensive care, until stepdown to the ward (and until the expected end of study on 30th April 2020)
|
Does the presence of a central venous catheter alter length of post-operative stay on the Intensive Care Unit
|
From admission to intensive care, until stepdown to the ward (and until the expected end of study on 30th April 2020)
|
|
Volume of blood product infused peri-operatively
Časové okno: From induction of anaesthesia until the end of the 12th post-operative hour
|
To assess whether the presence of a central venous catheter influences the volume of blood products infused peri-operatively
|
From induction of anaesthesia until the end of the 12th post-operative hour
|
|
Mean dose of required vasopressor agents
Časové okno: From induction of anaesthesia until the end of the 12th post-operative hour
|
To assess whether the presence of a central venous catheter influences the mean dose of any required vasopressor agents peri-operatively
|
From induction of anaesthesia until the end of the 12th post-operative hour
|
|
Use of cardiac output (flow-monitoring) equipment
Časové okno: From induction of anaesthesia until the end of the 12th post-operative hour
|
To assess whether the presence of a central venous catheter, and any ensuing fluid and blood pressure management strategies, influence the use of cardiac output monitoring equipment peri-operatively
|
From induction of anaesthesia until the end of the 12th post-operative hour
|
|
Length of hospital stay
Časové okno: From the day of the procedure until discharge from the hospital (and until the expected end of study on 30th April 2020)
|
To assess whether the presence of a central venous catheter influences the total post-operative length of stay
|
From the day of the procedure until discharge from the hospital (and until the expected end of study on 30th April 2020)
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Ředitel studie: David Melia, MBBS, Barts & The London NHS Trust
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další identifikační čísla studie
- 012593
- 19/LO/0099 (Jiný identifikátor: HREC)
- 252375 (Jiný identifikátor: IRAS)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Central Venous Catheter
-
Yonsei UniversityDokončenoBronchiektázie | Lymfangioleiomyomatóza | Primární plicní hypertenze | ARDS (syndrom akutní respirační tísně) | CHOPN (chronická obstrukční plicní nemoc) | Intersticiální plicní fibróza ARDSKorejská republika
-
Hospices Civils de LyonDokončeno
-
Toro Neurovascular, Inc.Zatím nenabírámeAkutní ischemická mrtviceFrancie
-
Fitlens Ltd.RSNESSNábor
-
Hamilton Health Sciences CorporationHealth CanadaDokončeno
-
Florida State UniversityNábor
-
Florida State UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)Dokončeno
-
Medical University of ViennaDokončenoMozková embolie | Komplikace dialýzy | Trombus způsobený zařízením pro renální dialýzu, implantátem nebo štěpemRakousko
-
Federico II UniversityNáborHepatocelulární karcinomItálie